James Arthur Bristol
CIK 1715153 · last filed 2026-06-29
James Arthur Bristol is a corporate insider who has filed 33 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for ERAS, was dated Jun 29, 2026. Across all open-market trades the lifetime net is −$9.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.77M
3
33
-$9.01M
Holdings By Company
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2026-01-05 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2025-02-10 | ERNA | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-04-29 | ERNA | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | ERAS | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.